Background: Population-specific risk models are required to build consumer and provider confidence in clinical service delivery, particularly when the risks may be life-threatening. Cardiac surgery carries such risks. Currently, there is no model developed on the Australian cardiac surgery population and this article presents a novel risk prediction model for the Australian cohort with the aim to provide a guide for the surgeons and patients in assessing preoperative risk factors for cardiac surgery. Aims: This study aims to identify preoperative risk factors associated with 30-day mortality following cardiac surgery for an Australian population and to develop a preoperative model for risk prediction. Methods: All patients (23 016) undergoing cardiac surgery between July 2001 and June 2008 recorded in the Australian Society of Cardiac and Thoracic Surgeons (ASCTS) database were included in this analysis. The data were divided randomly into model creation (13 810, 60%) and model validation (9206, 40%) sets. The model was developed on the creation set and then validated on the validation set. The bootstrap sampling and automated variable selection methods were used to develop several candidate models. The final model was selected from this group of candidate models by using prediction mean square error (MSE) and Bayesian Information Criteria (BIC). Using a multifold validation, the average receiver operating characteristic (ROC), p-value for Hosmer-Lemeshow chi-squared test and MSE were obtained. Risk thresholds for low-, moderate-and high-risk patients were defined. The expected and observed mortality for various risk groups were compared. The multicollinearity and first-order interaction effect between clinically meaningful risk factors were investigated. Results: A total of 23 016 patients underwent cardiac surgery and the 30-day mortality rate was 3.2% (728 patients). Independent predictors of mortality in the model were: age, sex, the New York Heart Association (NYHA) class, urgency of procedure, ejection fraction estimate, lipid-lowering treatment, preoperative dialysis, previous cardiac surgery, procedure type, inotropic medication, peripheral vascular disease and body mass index (BMI). The model had an average ROC 0.8223 (95% confidence interval (CI): 0.8118-0.8227), p-value 0.8883 (95% CI: 0.8765-0.90) and MSE 0.0251 (95% CI: 0.02515-0.02516). The validation set had observed mortality 3.0% (95% CI: 2.7-3.3%) and predicted mortality 2.9% (95% CI: 2.6-3.2%). The low-risk group (additive score 0-3) had 0.6% observed mortality (95% CI: 0.3-0.9%) and 0.5% predicted mortality (95% CI: 0.2-0.8%). The moderate-risk group (additive score 4-9) had 1.7% observed mortality (95% CI: 1.2-2.2%) and 1.4% predicted mortality (95% CI: 1.0-1.8%). The observed mortality for the high-risk group (additive score 9 plus) was 6.7% (95% CI: 5.8-7.6%) and the expected mortality was 6.7% (95% CI: 5.8-7.6%). Conclusion: A preoperative risk prediction model for 30-day mortality was developed for the Australian cardiac surgery population. #
Introduction
Accurate assessment of preoperative risk is essential for consumers and providers prior to undertaking relatively highrisk procedures such as open heart surgery. Methods to assess preoperative risk have been developed from several patient populations. However, it has been recognised that these risk estimates may be appropriate for the specific population rather than having global application across various populations. The US-derived Parsonnet (STS) model and the European System for Cardiac Operative Risk Evaluation (EuroSCORE) model [1, 2] are two examples of models being used to evaluate risk prior to cardiac surgery.
In 1986, the Society of Thoracic Surgeons (STS) in the United States established a voluntary National Cardiac Surgery Database (NCSD) (http://www.sts.org/outcomes) and developed risk models for predicting mortality for coronary artery bypass grafting, isolated aortic valve replacement and mitral valve replacement. Models developed based on the STS database are not available but the mortality risk can be calculated using their online risk calculator (http:// www.sts.org/sections/stsnationaldatabase/riskcalculator/). The STS model is revised on a regular basis. A divergence between observed and predicted mortality using the STS model was found in a recent analysis [3] . The EuroSCORE model was developed in 1999 based on 19 030 patients from 128 surgical centres in eight European countries. The EuroSCORE model has been validated in many populations, including the STS database [4] , in Japan [5] and in Cologne, France [6] . The ASCTS has applied the EuroSCORE model for mortality risk adjustment since the ASCTS database was commenced in 2001 [7] . However, recently Yap et al. have shown that the EuroSCORE model poorly predicts the mortality for the Australian population [8] .
Therefore, the aim of this study was to develop a model for predicting 30-day mortality following cardiac surgery for use in the Australian population. Our hypothesis was that a locally derived model will provide a higher level of discrimination and would be better calibrated for the Australian population than the models derived from other populations.
Methods

ASCTS database
Information about adult patients having cardiac surgery in 14 hospitals in Australia was collected prospectively by the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) since June 2001. In each centre, a data manager is responsible for the completeness of the data collection. All data are verified on receipt and data queries are generated about missing data, outliers or inconsistencies reported. Since the establishment of the ASCTS database in 2001, data validation has been a major focus. The data were validated locally and also by an external data quality audit program. This program was performed on-site to evaluate the completeness (<1% missing data for any variable) and accuracy of the data collected within the combined database. The report from the audit on quality of data was used to assist in further development of appropriate standards [9] .
The ASCTS database contains information on patient preoperative risk factors (including preoperative cardiac status and previous interventions), intra-operative details (including the procedure performed, myocardial protection and procedural duration), complications and postoperative outcomes. The database contains data on all patients who had cardiac surgery from 1 July 2001 to 30 June 2008. For this study, the outcome variable was mortality within 30 days of cardiac surgery. The 30-day mortality information was collected by the data manager by contacting medical practitioners, patients or family members by telephone as part of clinical care.
Statistical methods
Statistical software packages Stata (version 10) and R (version 2.3.1) were used for the analyses [10, 11] . In total, 2.6% of the patients were excluded from the analysis because of missing observations. The primary selection of 18 risk factors was made by evaluating the association between 30-day mortality and the risk factor. The variables with a p-value of less than 0.25 were identified as plausible predictors for 30-day mortality following cardiac surgery [12, 13] .
Bootstrap methods along with automated variable selection procedures were used to develop a parsimonious model using multiple logistic regression [12] . The data were divided into two sets: model creation set (n = 13 810, 60% of the total patients) and model validation set (n = 9206). In all, 1000 bootstrap samples (each of size of 13 810) were selected from the model creation set and a multiple logistic regression model was developed for each of the 1000 samples. The number of times each candidate variable was identified as significant in 1000 bootstraps was recorded and then ranked. In each bootstrap, a p-value of 0.05 or less was regarded as significant in the variable selection. Then we developed seven multiple logistic regression models with the variables selected in at least 100%, 90%, 80%, 70%, 60%, 50% and 10% (all variables) of bootstrap samples. In the creation set, the Bayesian Information Criteria (BIC) [14] and the prediction mean square error (MSE) were calculated for each of these models and the final model was selected based on the value obtained for the BIC and MSE. The prediction performance of the selected model was assessed by calculating average ROC, Hosmer-Lemeshow p-value and MSE from a multifold (100) validation on the validation set. The additive risk was obtained from the estimated beta coefficients of the proposed risk prediction model and the risk categories were defined such that the categories would be of similar size [2] . The observed and predicted mortalities were compared for some specific risk factors and also for the additive risk categories. The multicollinearity and first-degree interaction effect between clinically relevant risk factors were also investigated.
Results
In total, 23 016 patients were included in the study, 728 (3.2%) patients died within 30 days of surgery. Patients' A total of 18 preoperative variables were identified as candidate variables for the 30-day mortality. In 1000 bootstraps, the number of times each candidate variable appeared as significant in the multiple logistic regression models were recorded. The results are summarised in Table 2 . Age, urgency of procedure and procedure type were identified as significant in all bootstrap samples. Two variables: previous cardiac surgery and the NYHA class were selected as independent predictors in at least 90% of the samples. Inotropic medication and ejection fraction estimate were identified in at least 80% of the bootstrap samples. The following three variables were selected as predictors in at least 70% of the bootstrap samples: gender, hypercholesterolaemia (lipid-lowering treatment) and preoperative dialysis. Two variables, peripheral vascular disease and body mass index (BMI) were selected in at least 60% of the samples. Use of anticoagulant medication was selected in at least 50% of the bootstraps. The variables cardiogenic shock, family history of coronary artery disease, respiratory disease, use of nitrate medication and cerebrovascular disease were selected as independent predictors in less than 50% of the bootstrap samples.
Using the results in Table 2 , we developed seven plausible risk prediction models. The average ROC, Hosmer-Lemeshow p-value and prediction MSE for each candidate model are reported in Table 3 . The model with variables selected in at least 60% of the samples had the minimum BIC and MSE; hence this model is our final model for predicting 30-day mortality. The risk factors in the final model are: age, gender, NYHA class, urgency of procedure, ejection fraction estimate, hypercholesterolaemia (lipid-lowering treatment), preoperative dialysis, previous cardiac surgery, procedure type, inotropic medication, peripheral vascular disease and BMI. There is no evidence of first-order interaction and multicollinearity between the risk factors in the model. The average ROC (0.8223, 95% CI: 0.8118-0.8227) and p-value (0.8883, 95% CI: 0.8765-0.90) show that the discrimination and calibration of our model are very good. A single validation of our proposed model had an ROC 0.8131 and the Hosmer-Lemeshow p-value 0.81 (see Fig. 1 for ROC curve).
The beta coefficients and odds ratio for the risk factors of the model are reported in Table 4 . The beta coefficients for gender, hypercholesterolaemia and BMI are negative. The beta coefficients can be used to predict preoperative mortality risk for a patient who is due to undergo cardiac surgery.
The additive risk scores are also shown in Table 4 . The mean additive score for the non-survivors was significantly higher than the survivors (mean scores survived 6.9, died 15.3, p-value <0.001). The mean logistic score for the nonsurvivors was also significantly higher than that for the survivors (mean risk survived 2.7%, died 11.8%, pvalue<0.001). The observed and predicted mortality for some specific risk factors and for the additive risk groups are shown in Table 5 . In the validation dataset, the overall observed mortality was 3.0% (95% CI: 2.7-3.3%) and predicted mortality was 2.9% (95% CI: 2.6-3.2%). The lowrisk patients had 0.6% observed mortality (95% CI: 0.3-0.9%) and 0.5% predicted mortality (95% CI: 0.2-0.8%). The moderate-risk patients had 1.7% observed mortality (95% CI: 1.2-2.2%) and 1.4% predicted mortality (95% CI: 1.0-1.8%). The high-risk group had 6.7% observed mortality (95% CI: 5.8-7.6%) and 6.7% predicted mortality (95% CI: 5.8- 
Discussion
An Australian preoperative risk model for prediction of 30-day mortality following cardiac surgery was developed. A close observed and predicted mortality for various risk sets demonstrates high-quality prediction performance of the model. Thus the model will allow a better assessment of preoperative risk for both surgeons and patients to consider.
The ROC for cardiac predictive models in the literature varies from 0.750 to 0.836 [15] [16] [17] [18] [19] [20] . Thus the performance of our proposed model with 12 variables (average ROC = 0.8223 and p-value = 0.8883) is comparable to models developed in the literature and better than most models, including the widely used EuroSCORE model (ROC = 0.759, p-value = 0.6775). Yap et al. showed that the EuroSCORE does not calibrate well for the Australian data [8] . The EuroSCORE for the Australian data has an ROC 0.820 and a p-value less than 0.05 -meaning the model calibrated poorly for the Australian data. This may be because the model is about 10 years old and has not been updated since its development in 1999. Patient demographics, clinical characteristics and cardiac surgical practice are changing over time. The introduction of percutaneous coronary interventions, including stenting, also has an impact on current cardiac surgical practice. Furthermore, the cardiac surgery risk factors may Additive score: The additive score was obtained by a linear transformation of the beta coefficients. The beta coefficient of each risk factor was divided by the absolute value of the lowest coefficient and then multiplied it by 2.1, and was rounded to the nearest integer [23] .
not be the same across populations and there are differences between the Australian and European data definitions [3, 8] .
The bootstrap method of variable selection for the risk prediction model was proposed to minimise the limitations of automated variable selection methods, namely backward elimination and forward selection methods. Automated selection methods have been shown to select noise variables as independent predictors [12] and the related p-values for goodness-of-fit test are biased downwards [21] . Hence, one should not rely solely on assessing the statistical significance of the predictors obtained using automated variable selection methods. By contrast, the bootstrap method can be used to assess the strength of evidence that a selected variable in the model is indeed an independent predictor of mortality. It is expected that the bootstrap method will identify the truly independent predictors in the majority of the bootstrap samples; however, the noise variables would be selected as independent predictors in a minority of samples. The risk prediction model development methods (bootstrap method along with the automated method) used in the present analyses provides a stable model compared with the backward elimination or forward selection method. We have used information criteria (BIC) and prediction MSE based model selection approach which, in theory, lead to a more robust model than the model selected based on the goodness of fit. Further, the model's high discrimination and calibration in the n-fold validation demonstrate that the model is very stable.
The odds ratio for males, treated with lipid-lowering medication (presence of hypercholesterolaemia) and overweight (BMI >25 kg m À2 ) show that these variables are protective for cardiac surgery mortality. The issue of BMI >25 having a protective effect is consistent with 'increased BMI not being associated with death following cardiac surgery' (Wigfield et al. who reported on those with BMI >40 having no increase in risk of death) [22] .
The beta coefficients for the model can easily be used to predict the 30-day mortality for a patient. Let us consider a female patient aged 83 years (beta coefficient is 1.3304), who will undergo emergency (beta coefficient is 1.6503) valve(s) surgery (beta coefficient is 0.6625), is classified as NYHA class III (beta coefficient is 0.4180) and has a moderate ejection fraction estimate (beta coefficient is 0.3683). The patient is also currently on inotropic medication (beta coefficient is 1.2183). The constant term is À5.1723. The sum of the beta coefficients and the constant term is 0.0575. Hence, the predicted risk is exp(0.0575)/(1 + exp(0.0575)) = 51.4% (for more case studies see Table 6 ). The 95% CI for the predicted risk is 32.3-70.2%.
A limitation of this study may be the limited number of hospitals (14 hospitals) in Australia that contributed data for Table 5 Comparison of observed and predicted mortality in the validation dataset.
Risk factor
Observed % (95% CI) Predicted % (95% CI) Table 6 Case-studies, risk prediction using logistic regression beta coefficients. this analysis and six of them being from one Australian state. We plan to avoid this by expanding ASCTS database to surgical units across Australia and we would propose a review of this model following the compilation of 50 000 cases. The choice of 30-day mortality and derivation of risk categories (instead of risk for individual additive scores) may also be limitations of this study. However, we have used 30-day mortality because currently 30-day mortality is most commonly used as a standard performance quality indicator for cardiac surgery. Further, it helps to compare the prediction performance of our model with the most widely used EuroSCORE model and the STS model where these models consider 30-day mortality as the outcome variable. The risk categories were also derived for similar comparison purposes. However, for high-risk patients the mortality risk could be predicted using beta coefficients. In future, we aim to consider a longer time period for postoperative mortality outcome (e.g., 180 days) and to report individual risk for additive scores. Another limitation of this study is the use of categorical BMI. However, the use of categorical measures in preference to continuous values is much easier to interpret for both surgeons and patients in preference to the impact of a one unit change in BMI.
Risk factors
Conclusion
We have developed a 12-variable multiple logistic regression model for predicting risk of 30-day mortality for cardiac surgery. The bootstrap method of variable selection is the strength of this model compared with similar models in the literature. The performance of our model is comparable to the mortality models proposed in the literature and better than the widely used EuroSCORE model for its own data and its application to the Australian data. The proposed model will help validate (risk-adjusted) comparisons between hospitals/surgeons contributing data. This model will also help both patients and surgeons to assess the preoperative risks for surgery. We recommend the use of this model in predicting 30-day cardiac mortality for the Australian cardiac surgery population.
